Busulfan

CAS 55-98-1 10 FDA-DMF suppliersSmall Molecule

Overview

Busulfan is a chemotherapy drug that acts as an alkylating agent, primarily used in bone marrow transplantation conditioning regimens. It helps destroy bone marrow and malignant cells in chronic myelogenous leukemia treatment.

API suppliers (8)

Suppliers of Busulfan backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • APICORE US LLCUnited States1 active DMF
  • APICORE US LLCUnited States1 active DMF
  • Emcure Pharmaceuticals LimitedIndia1 active DMF
  • SHILPA PHARMA LIFESCIENCES LTD1 active DMF
  • ARTHUR GROUP LLC1 active DMF
  • FRESENIUS KABI ONCOLOGY LTD
  • EXCELLA GMBH AND CO KG
  • EUTICALS SPAItaly

Therapeutic areas

OncologyHematology

Related APIs

Deferasirox
24 suppliers
Azacitidine
21 suppliers
Lenalidomide
20 suppliers
Ibrutinib
16 suppliers
Gemcitabine Hydrochloride
10 suppliers
Midostaurin
10 suppliers
Ixazomib
7 suppliers
Romidepsin
6 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo